Tscan therapeutics to participate in the morgan stanley 20th annual global healthcare conference

Waltham, mass., sept. 07, 2022 (globe newswire) -- tscan therapeutics, inc. (nasdaq: tcrx), a clinical-stage biopharmaceutical company focused on the development of t cell receptor (tcr) engineered t cell therapies (tcr-t) for the treatment of patients with cancer, today announced that management will participate in a fireside chat at the morgan stanley 20th annual global healthcare conference being held at the sheraton new york in new york, ny on wednesday, september 14, 2022 at 12:55 p.m. et.
TCRX Ratings Summary
TCRX Quant Ranking